Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonistic CD40 monoclonal antibodies and uses in treating immune responses

Antagonistic CD40 monoclonal antibodies and uses in treating immune responses

US Patent 11254750 · Granted Feb 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glypican-3-binding fibronectin based scaffold molecules2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use2025